Figure 3. Comparison of the Relative Change in Serum anti-MAG IgM Titers or Levels Between Responder, Nonresponder, and Acute Deteriorating Groups.
Comparison of clinical improvement and relative change in serum anti-MAG IgM titers, paraprotein levels, and total IgM levels in the (A) responder group, (B) nonresponder group, (C) and the acute deteriorating group. Data are shown as median and 95% confidence intervals. MAG = myelin‐associated glycoprotein.